期刊文献+

消融阻隔气囊的动物实验研究 被引量:1

Experimental study of the ablation-separating balloon in swine
原文传递
导出
摘要 目的通过家猪实验,研究消融阻隔气囊在肝脏射频消融治疗中的保护作用。方法5只猪全麻后在CT引导下行射频消融治疗,针对消融阻隔气囊的保护作用行随机对照实验研究。每只猪均取两个治疗区,实验区加用消融阻隔气囊保护,对照区不用阻隔气囊。术后3~4d处死猪,观察组织坏死病理变化并测量坏死组织面积:结果实验组和对照组各有5个治疗区,实验组消融时间为(18.2±2.6)min,肝坏死组织的最大直径为(4.9±0.5)cm;对照组消融时间为(16.0±1.8)min,肝组织坏死最大直径为(4.6±0.6)cm,两组治疗时间和肝组织坏死最大直径差异无统计学意义(P〉0.05)。实验组无膈肌损伤,对照组膈肌均有热损伤,瞩肌损伤面积平均(5.2±2.0)cm^2,两例出现穿孔。结论消融阻隔气囊可在行射频消融时有效保护邻近器官,减少热损伤并发症. Objective To evaluate protective effect of using ablation-separating balloon during liver radiofrequence ablation(RFA) in swine. Methods Five swines were received liver RFA under real-time CT guidance after general anaesthesia, A randomized control trial about protective effect of using ablation-separating balloon was carried out. Each swine received twice RFA in its liver adjacent to diaphragm. Experimental region was protected with ablation-seperating balloon, and control region was treated without protection. The swines were sacrificed 3 to 4 d after RFA. Pathologic changes were observed and liver necrosis area was measured. Results Every, group had 5 regions of RFA. Average duration of RFA in experimental group was (18.2±2.6) rain, and that in control group was (16.0±1.8) rain. The maximum diameter of liver necrosis in experimental group was (4.9±0.5 ) cm, and that in control group was (4.6±0.6) cm. The average duration of RFA and maximum diameter of liver neocrosis had no significant difference (P〉0.05). There was no diaphragmatic thermal injury in experimental group, but diaphragmatic thermal injury was observed in all the swines in control group. The average injury area of diaphragm was (5.2±2.0) cm^2, and perforation of diaphragm took place in two swines. Conclusion The ablation-seperating balloon can effectively protect adjacent tissue to target organ of RFA, and reduce complications of thermal injury.
出处 《中华生物医学工程杂志》 CAS 2009年第1期61-64,共4页 Chinese Journal of Biomedical Engineering
关键词 消融术 射频 术后并发症 气囊 热损伤 膈肌 Ablation, radiofrequency Postoperative complications Balloon Thermalinjuly Diaphragm
  • 相关文献

参考文献13

  • 1Mulier S, Mulier P, Ni Y, et al. Complications of radiofrequency coagulation of liver turnouts. Br J Surg, 2002, 89 : 1206-1222.
  • 2Livraghi T, Solbiati L, Meloni MF, et al. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encounteredinamulticenterstudv. Radiology,2003, 226:441-451.
  • 3姜勇.消融治疗阻隔气囊:中国,200620063644.2008.01-02.
  • 4陈敏华,严昆,杨薇,高文,戴莹,王艳滨,张晖,霍苓,邢宝才,黄信孚.343例肝恶性肿瘤射频消融疗效及并发症[J].北京大学学报(医学版),2005,37(3):292-296. 被引量:64
  • 5马庆久,王青,鲁建国,高德明,赵柏山,卞玲.集束电极射频消融治疗肝癌术后并发症的原因分析及其防治[J].中华外科杂志,2003,41(11):805-808. 被引量:10
  • 6Komorizono Y, Oketani M, Sako K, et al. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer, 2003, 97:1253-1262.
  • 7Mulier S, Ni Y, Jamart J, et al. Local recurrence after hepatic radiofrequency coagulation: muhivariate meta-analysis and review of contributing factors. Ann Surg, 2005, 242: 158-171.
  • 8夏景林,叶胜龙,邹静怀,任正刚,干育红,王艳红,陈漪,葛宁灵,汤钊猷,杨秉辉.单次经皮射频消融治疗小肝癌的预后及复发危险因素分析[J].癌症,2004,23(9):977-980. 被引量:14
  • 9Rhim H, Lira HK, Kim YS, et al. Pereutaneous radiofrequency ablation with artificial ascites for hepatocellular carcinoma in the hepatic dome: initial experience. Am J Rocntgenol, 2008, 190: 91-98.
  • 10陈敏华,严昆,戴莹,杨薇,高文,廖盛日,吴薇,张晓鹏,黄信孚.经皮射频治疗肝肿瘤中肠穿孔预防措施探讨[J].中国介入影像与治疗学,2005,2(4):256-260. 被引量:10

二级参考文献44

  • 1Lencioni RA, Allgaier HP, Cioni D, et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio frequency thermal ablation versus percutaneous ethanol injection [J]. Radiology, 2003, 228 (1): 235- 240.
  • 2Ikeda M, Okada S, Ueno H, et al. Radiofrequency ablation and percutaneous ethanol injection in patients with small hepatocellular carcinoma: a comparative study [J]. Jpn J Clin Oncol, 2001, 31(7):322- 326.
  • 3Livraghi T, Goldberg SN, Lazzaroni S, et al. Small hepatocellular carcinoma: treatment with radio frequency ablation versus ethanol injection [J]. Radiology, 1999, 210(3): 655- 661.
  • 4Curley SA, Izzo F, Ellis LM, et al. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis [J]. Ann Surg, 2000, 232(3): 381- 391.
  • 5Komorizono Y, Oketani M, Sako K, et al. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation [J]. Cancer, 2003, 97(5):1253- 1262.
  • 6Rossi S, Di Stasi M, Buscarini E, et al. Percutaneous radiofrequency interstitial thermal ablation in the treatment of small hepatocellular carcinoma [J]. Cancer J Sci Am, 1995, 1(1): 73.
  • 7Rhim H, Dodd GD 3rd. Radiofrequency thermal ablation of liver tumors [J]. J Clin Ultrasound, 1999, 27(5): 221- 229.
  • 8Rossi S, Garbagnati F, De Francesco I, et al. Relationship between the shape and size of radiofrequency induced thermal lesions and hepatic vascularization [J]. Tumor, 1999, 85(2): 128- 132.
  • 9Bilchik AJ, Wood TF, Allegra DP, et al. Radiofrequency ablation of unresectable hepatic malignancies: lessons learned [J]. Oncologist, 2001, 6(1): 12- 13.
  • 10Lu DS, Raman SS, Limanond P, et al. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors [J]. J Vasc Interv Radiol, 2003,14(10): 1267- 1274.

共引文献89

同被引文献9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部